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EDITORIAL Open Access
Implementing PRISMA-P: recommendations
for prospective authors
David Moher1,2*, Lesley Stewart1,3 and Paul Shekelle1,4
Systematic reviews have become very popular. A recent
estimate suggests that 22 new systematic reviews are
published daily [1]. One reason for this interest is that
they serve many purposes. For example, the influential
Institute of Medicine has indicated that a systematic re-
view is an essential component when developing clinical
practice guidelines within the USA [2]. Some granting
agencies are now advocating for the use of systematic
reviews as an evidence-based rationale for the conduct
of a proposed randomized trial [3]. And journals are
now demanding the use of systematic reviews to provide
readers with context of the results of a clinical trial [4].
For systematic reviews to be useful, they need to be
reported in the highest possible quality thus facilitating
their accurate use across a wide spectrum of stakeholders,
including patients. Unfortunately, surveys of the published
literature indicate that the quality of reporting is not opti-
mal. For example, there is evidence indicating that report-
ing biases, particularly selective outcome reporting, is
prevalent. An early example of differences between out-
comes reported in protocols and the paired completed
review was an examination of 47 Cochrane reviews in
which 43 (91 %) contained a major change, such as the
addition or deletion of outcomes, between the protocol
and the full publication [5]. More recently, in an examin-
ation of 485 Cochrane protocol-review pairs, 38 % (95 %
CI 23 to 54 %) were found to have discrepant outcomes
(i.e., added, omitted, or changed the priority) between the
protocol and completed review [6]. The vast majority of
these discrepancies were without attribution with more
significant outcomes being upgraded or added. Whether
or not, and to what extent, these examples reflect report-
ing biases is not clear. However, they represent inconsist-
encies that should be avoided by authors.
The gold standard for identifying reporting biases is a
comparison of the completed review with its paired proto-
col. Such an examination is difficult with systematic reviews
as too few of them report working from a protocol, al-
though a growing number of funders are now requiring
them. Perhaps, systematic reviewers do not report or use
protocols because there has been little guidance on how to
report them until recently. To help facilitate the use of
reporting systematic review protocols, the three of us and
several colleagues developed Preferred Reporting Items for
Systematic Review and Meta-Analysis Protocols (PRISMA-
P) [7]. This is a reporting guideline consisting of a 17-item
checklist, to help prospective authors in the preparation
and reporting of a scientifically rigorous systematic review
protocol. We also prepared a pedagogical explanation and
elaboration document to facilitate its use [8]. Readers
appear interested in the guidance. Since its publication a
little more than a year ago, it has been downloaded about
45,000 times and cited (Google scholar) nearly 100 times.
This journal and others have endorsed PRISMA-P. Here,
we describe how the journal intends to implement it.
All protocol submissions to the journal should use
continuous line numbering in their manuscript. Authors
should also include a completed PRISMA-P checklist indi-
cating whether or not the requested item information is
reported (by completing the check mark). If the item is
checked, authors should then specify the line number (or
range of line numbers) where this information is described.
Manuscripts accepted for publication will have the com-
pleted PRIMSA-P checklist (on submission) included as an
Appendix to their publication, which must be referenced
within the main text (Additional file 1). Prospective authors
can download a Word version of the PRISMA-P checklist,
which includes the two added columns, from the journal’s
website (URL to be added)or the PRISMA website
(ttp://www.prisma-statement.org/Extensions/Protocols.aspx).
If PRISMA-P was used to help report the protocol, it
should be cited or the PRISMA-P URL (http://
www.prisma-statement.org/Extensions/Protocols.aspx) on
the PRISMA website should be reported.
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About half of what the journal publishes are protocols of
systematic reviews. We want to ensure they are published
to the highest possible quality. Endorsement and imple-
mentation of reporting guidelines appears to improve the
completeness of reporting. For example, a systematic re-
view examining the completeness of reporting in more than
16,000 randomized trials in journals that endorsed the
CONSORT statement, compared to journals that did not,
found more complete reporting [9]. Similarly, examining
300 systematic reviews published in February 2014 found
that mention of PRISMA was associated with better report-
ing [1].
There is always a tension between an optimal imple-
mentation strategy and ensuring minimal barriers to sub-
mission for prospective authors. We believe the journal
has achieved a good balance with this strategy. Protocols
submitted for publication consideration from now on that
do not include a completed checklist, including the two
aforementioned columns, will be returned to the authors
with instructions about the journal’s systematic review
protocol implementation strategy and invited to resubmit
their continuously line numbered manuscript and appro-
priately completed checklist.
Additional file
Additional file 1: PRISMA-P 2015 Checklist. This checklist has been
adapted for use with protocol submissions to Systematic Reviews from
Table 3 in Moher D et al: Preferred reporting items for systematic review
and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic
Reviews 2015 4:1.
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